HOUSTON, Feb. 7, 2017 /CNW/ -- Nobilis Health
Corp. (NYSE MKT: HLTH) ("Nobilis" or the "Company") today
announced the appointment of Mr. David
Young as its Chief Financial Officer. Mr. Young brings
to Nobilis extensive Fortune 500 company executive experience in
corporate finance, financial planning, and cost management in
healthcare.
"We are excited to welcome David to the leadership team at
Nobilis. He will unquestionably make an immediate impact on
our financial operations as we continue to grow nationally.
We have expanded our markets and facilities over the last three
years which has created the need for us to bring deeper experience
to the finance team. David brings the track record of a
successful chief financial officer in managing national level
portfolios along with his experience as a seasoned operations
executive. His skills and integrity are important attributes that
he brings to the executive team as Nobilis continues its aggressive
growth," said Harry Fleming, Chief
Executive Officer of Nobilis. "David's primary focus will be to
manage Nobilis' bottom line to keep up with our rapid growth.
Nobilis will continue to bring in experienced executives to manage
its rapidly growing national presence," continued Fleming.
Most recently, Mr. Young served as Senior Vice
President/Division CFO of St. Jude Medical Inc.'s Americas
Division, where he implemented innovative cost structures that
generated substantial cost savings and improved overall
profitability during his tenure. Prior to St. Jude, Mr. Young served as Vice President
of Finance at Thermo Fisher Scientific, an $18 billion life sciences research company, which
has over 55,000 employees globally. Prior to his role at
Thermo Fisher Scientific, Mr. Young was Vice President of Finance
at Cardinal Health.
Mr. Young will succeed Kenny
Klein, who will remain at Nobilis in a finance leadership
role focusing on the company's Hospital Division. "Nobilis has a
history of strong revenue performance. As we build on that
history and continue our aggressive acquisition strategy we need to
strengthen our integration process and ensure a culture of focus
and discipline when managing our cost structure, beginning with the
Hospital Division. With 24 locations in seven states,
including 4 hospitals, 10 ASCs and 10 clinics, efficient operations
will become critical to the company's continued success," stated
Mr. Young.
Mr. Young began his career at KPMG, as an auditor for a variety
of industries, including healthcare. Mr. Young is a licensed
CPA and holds an M.B.A. from the University of
Texas, McCombs School of
Business.
About Nobilis Health Corp.
Nobilis (www.NobilisHealth.com) is a full-service healthcare
development and management company, with 24 locations in seven
states, including 4 hospitals, 10 ASCs and 10 clinics. In addition,
Nobilis partners with an additional 38 facilities across the
country. Marketing eight independent brands, Nobilis deploys a
unique patient acquisition strategy driven by proprietary
direct-to-consumer marketing technology, focusing on a specified
set of procedures that are performed at our centers by local
physicians.
Forward Looking Statements
This press release contains certain forward-looking statements
within the meaning of Canadian and United
States securities laws, including the safe harbor for
forward-looking statements contained in the Private Securities
Litigation Reform Act of 1995. Forward-looking statements include
all statements that do not relate solely to historical or current
facts and may be identified by the use of words such as "may,"
"believe," "will," "expect," "project," "estimate," "anticipate,"
"plan" or "continue." These forward-looking statements are based on
current plans and expectations and are subject to a number of
risks, uncertainties and other factors which could significantly
affect current plans and expectations and our future financial
condition and results. These factors, which could cause actual
results, performance and achievements to differ materially from
those anticipated, include, but are not limited to our ability to
successfully maintain effective internal controls over financial
reporting; our ability to implement our business strategy, manage
the growth in our business, and integrate acquired businesses; the
risk of litigation and investigations, and liability claims for
damages and other expenses not covered by insurance; the risk that
payments from third-party payers, including government healthcare
programs, may decrease or not increase as costs increase; adverse
developments affecting the medical practices of our physician
limited partners; our ability to maintain favorable relations with
our physician limited partners; our ability to grow revenues by
increasing case and procedure volume while maintaining
profitability at the Nobilis facilities; failure to timely or
accurately bill for services; our ability to compete for physician
partners, patients and strategic relationships; the risk of changes
in patient volume and patient mix; the risk that laws and
regulations that regulate payments for medical services made by
government healthcare programs could cause our revenues to
decrease; the risk that contracts are cancelled or not renewed or
that we are not able to enter into additional contracts under terms
that are acceptable to us; and the risk of potential decreases in
our reimbursement rates. The foregoing are significant factors we
think could cause our actual results to differ materially from
expected results. However, there could be additional factors
besides those listed herein that also could affect us in an adverse
manner.
We have not undertaken any obligation to publicly update or
revise any forward-looking statements. All of our forward-looking
statements speak only as of the date of the document in which they
are made or, if a date is specified, as of such date. Subject to a
mandatory requirements of applicable law, we disclaim any
obligation or undertaking to provide any updates or revisions to
any forward-looking statement to reflect any change in our
expectations or any changes in events, conditions, circumstances or
information on which the forward-looking statement is based. All
subsequent written and oral forward-looking statements attributable
to us or persons acting on our behalf are expressly qualified in
their entirety by the foregoing factors and in our Annual Report on
Form 10-K for the fiscal year ended December
31, 2015, filed on March 15,
2016, as updated by other filings with the Securities and
Exchange Commission.
Contact:
Tuan Tran
Director of Investor Relations
TTran@nobilishealth.com
713-355-8614
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nobilis-health-corp-announces-the-appointment-of-david-young-as-chief-financial-officer-300403750.html
SOURCE Nobilis Health Corp.